{"nct_id":"NCT02092922","title":"A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2014-05","start_date_type":"ACTUAL","primary_completion_date":"2016-07","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}